Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Shares Issued (2016 - 2025)

Mimedx (MDXG) has disclosed Shares Issued for 15 consecutive years, with -$1000.0 as the latest value for Q4 2025.

  • Quarterly Shares Issued changed 0.0% to -$1000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 million through Dec 2025, down 11.71% year-over-year, with the annual reading at $1.6 million for FY2025, 0.19% changed from the prior year.
  • Shares Issued hit -$1000.0 in Q4 2025 for Mimedx, down from $737000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $915000.0 in Q1 2021 to a low of -$1000.0 in Q4 2023.
  • Historically, Shares Issued has averaged $379611.1 across 5 years, with a median of $242000.0 in 2022.
  • Biggest YoY gain for Shares Issued was 402.19% in 2023; the steepest drop was 101.3% in 2023.
  • Year by year, Shares Issued stood at $33000.0 in 2021, then soared by 133.33% to $77000.0 in 2022, then crashed by 101.3% to -$1000.0 in 2023, then changed by 0.0% to -$1000.0 in 2024, then changed by 0.0% to -$1000.0 in 2025.
  • Business Quant data shows Shares Issued for MDXG at -$1000.0 in Q4 2025, $737000.0 in Q3 2025, and $848000.0 in Q1 2025.